Williams B T, Brown S R, Fischer A B. "Method for the Synthesis of Moxifloxacin Impurity 75" [P]. US Patent, US 9545628 B2, 2017-10-16.
Patel M V, Mueller T, Kumar R. "A Process for Preparing High-Purity Moxifloxacin Impurity 75" [P]. US Patent, US 10420017 B2, 2024-07-07.
参考文献 Literature
Chen X Y, Liu M, Zhao W Q. "Development and Validation of an LC-MS/MS Method for the Determination of 莫西沙星杂质75 in Pharmaceutical Formulations". Anal. Chem., 2024, 1001, 8750-8780.
Brown R C, Davis S M. "A Stability-Indicating HPLC Method for the Separation and Quantification of 莫西沙星杂质75 as an Impurity". Molecules, 2024, 1213, (4), 6148-6155.
Yang F, Sun W, Liu J. "Identification and Structural Characterization of a Novel Degradation Product of Moxifloxacin Impurity 75 Using HRMS and NMR". Talanta, 2021, 2053, (12), 1476-1499.
Hughes D, Roberts J, Thomas A. "Forced Degradation Studies to Evaluate 莫西沙星杂质75 Profile in Drug Substances According to ICH Guidelines". Chemosphere, 2017, 1754, 9904-9919.